Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Minority Interest (2018 - 2025)

BioCorRx (BICX) has disclosed Minority Interest for 8 consecutive years, with -$303429.0 as the latest value for Q4 2025.

  • Quarterly Minority Interest fell 29.22% to -$303429.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$303429.0 through Dec 2025, down 29.22% year-over-year, with the annual reading at -$303429.0 for FY2025, 29.22% down from the prior year.
  • Minority Interest hit -$303429.0 in Q4 2025 for BioCorRx, down from $720344.0 in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $720344.0 in Q3 2025 to a low of -$389027.0 in Q2 2025.
  • Historically, Minority Interest has averaged -$118220.0 across 5 years, with a median of -$126744.0 in 2023.
  • Biggest YoY gain for Minority Interest was 519.31% in 2025; the steepest drop was 166.15% in 2025.
  • Year by year, Minority Interest stood at -$117838.0 in 2021, then fell by 6.3% to -$125257.0 in 2022, then dropped by 2.86% to -$128834.0 in 2023, then tumbled by 82.26% to -$234812.0 in 2024, then dropped by 29.22% to -$303429.0 in 2025.
  • Business Quant data shows Minority Interest for BICX at -$303429.0 in Q4 2025, $720344.0 in Q3 2025, and -$389027.0 in Q2 2025.